Slide 1

1306 / 1332

Inclusion criteria:
1. Biopsy proven cervical Ca
2. Treatment with curative intent
3. FIGO, TNM staged
4. MRI/CT pelvis and PAN at diagnosis
5. MR guided BT planned
6. Informed consent (copy to the study office)
Registration
form
Status at diagnosis form
(MRI + CRF + cartoons)
Baseline morbidity
form
Baseline QoL
TREATMENT
Status at BT
form
Treatment and DVH form
(EBRT +/- Chemo + BT1-n)
EBRT+/-
Chemo
Follow-up Follow-up
form
Toxicity assessment
Disease status
POSTREATMENT
MRI guided
BT
DIAGNOSIS
QoL form
Every 3 months for 2 years;
Every 6 months for 3 years
Local recurrence or
toxicity G>2
COMPREHENSIVE
REPORT TO STUDY
OFFICE!!!
Off study form
End of treatment QoL form